Dapoxetine Impurity N3 CAS 4436-22-0

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.4436-22-0
Molecular FormulaC9H10O
Molecular Weight134.18 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Dapoxetine Impurity N3 CAS 4436-22-0 chemical structure

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Dapoxetine Impurity N3.

Dapoxetine Impurity N3 (CAS 4436-22-0) is a certified pharmaceutical impurity reference standard with the molecular formula C9H10O and a molecular weight of 134.18 g/mol.

The molecular framework of Dapoxetine Impurity N3 (C9H10O) is characterized by a hydroxyl group, an ether linkage, an aromatic ring system. In reversed-phase chromatography, its retention is governed primarily by the polarity and ionization state of its functional groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.

Physical & Chemical Properties

Molecular FormulaC9H10O
Molecular Weight134.18 g/mol
Purity97%+
StorageStore at 2-8°C
Solubility (reference)Soluble in methanol, acetonitrile, DMSO, water (slightly soluble)
StabilityStable under recommended storage conditions
Degree of Unsaturation (DBE)5.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1958

Related Dapoxetine Standards

Recommended Standards

Why CATO?